Skip to main content
. 2017 Jan 3;8(10):17328–17346. doi: 10.18632/oncotarget.14461

Table 2. Dysregulated microRNAs in sera or plasma samples in patients with colorectal cancer.

Source Dysregulation Number of studies microRNAs and references
Sera Upregulated 3 miR-92a[85, 148, 149]; miR-221[149151]
2 miR-21[45, 152]; miR-210[85, 149]
1 miR-19a[149]; miR-22*[149]; miR-24[149]; miR-92[153]; miR-125a-5p[149]; miR-134[150]; miR-141[154]; miR-146a[150]; miR-320a[85]; miR-376a[149]; miR-378[85]; miR-423-5p[85]; let-7e[149] ; miR-222[150]; miR-423-5p[85]
Downregulated 2 miR-143[85, 89]
1 miR-10a[149]; miR-103[85]; miR-106a[85], miR-107[85]; miR-141[149]; miR-145[96]; miR-150[149]; miR-151-5p[85]; miR-188-3p[149]; miR-192[149]; miR-199a-3p[85]; miR-224*[149]; miR-382[85]; miR-425*[149]; miR-495[149]; miR-572[149]; miR-601[149]; miR-720[149]; miR-760[149]; let-7a[149]; let-7d[85]